Frequencies for first 10,000 rows of rx2v2c2 variable in nhamcsopd2006 dataset : for rx2, level 2 of multum drug | category #2 | Freq. Percent Cum. ----------------------------------------+----------------------------------- Anti-infectives: antimalarial agents | 17 0.17 0.17 Anti-infectives: miscellaneous antibiot | 7 0.07 0.24 Anti-infectives: sulfanomides | 21 0.21 0.45 Metabolic agents: antihyperlipidemia ag | 4 0.04 0.49 Cardiovascular agents: diuretics | 1 0.01 0.50 Cardiovascular agents: vasodilators | 4 0.04 0.54 CNS: Anticonvulsants | 76 0.76 1.30 CNS: Antiemetic/antivertigo agents: 5HT | 75 0.75 2.05 CNS: Anti-Parkinson agents | 1 0.01 2.06 Coagulation modifiers: antiplatelet age | 60 0.60 2.66 Hormones: adrenal cortical steroids | 18 0.18 2.84 Hormones: sex hormones | 14 0.14 2.98 Miscellaneous agents: antidotes | 1 0.01 2.99 Miscellaneous agents: local injectable | 53 0.53 3.52 Miscellaneous agents: genitourinary tra | 1 0.01 3.53 Nutritional products: minerals and elec | 4 0.04 3.57 Respiratory agents: antihistamines | 41 0.41 3.98 Respiratory agents: antitussives | 6 0.06 4.04 Respiratory agents: decongestants | 10 0.10 4.14 Respiratory agents: miscellaneous respi | 4 0.04 4.18 Respiratory agents: respiratory inhalan | 2 0.02 4.20 Topical agents: dermatological agents | 11 0.11 4.31 Topical agents: mouth and throat prod | 4 0.04 4.35 Topical agents: vaginal preprations | 11 0.11 4.46 Miscellaneous agents: antirheumatics | 11 0.11 4.57 Alternative medicines: nutraceutical pr | 2 0.02 4.59 Psychotherapeutic agents: antidepressan | 4 0.04 4.63 Psychotherapeutic agents: antipsychotic | 7 0.07 4.70 Gastrointestinal agents: 5-aminosalicyl | 1 0.01 4.71 Metabolic agents: antihyperuricemic age | 3 0.03 4.74 Cardiovascular agents: agents for pulmo | 1 0.01 4.75 Miscellaneous agents: smoking cessation | 39 0.39 5.14 Cardiovascular agents: aldosterone rece | 5 0.05 5.19 . | 9,481 94.81 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 28 Mar 2016